Age is a more accurate prognosticator.
The long-term COVID-19 aftermath requires new strategies.
Editorial calls for a pan-SARS-CoV-2 vaccine.
People's perception of risk associated with vaping products examined.
Findings might provide solution to vaccine shortages.
An important article for anyone who has attempted to administer prednisolone to a young child having an asthma attack.
Bamlanivimab monotherapy was ineffective in this phase 2/3 trial.
Meta-analysis finding is independent of sex, smoking status, BMI, and geographical region.
Findings using data from 2 UK cohorts.
Age and sex may also play a role.
Former and current smokers with more frequent acute respiratory events have accelerated loss of skeletal muscle.
Combination of bamlanivimab and etesevimab cuts hospitalization and death rate by 70%.
Evolving data indicate European SARS-CoV-2 circulation much earlier than reported.
No increase in serious bleeding observed.
Phase 2 placebo-controlled trial of peginterferon lambda shows steeper viral load decline.
In a randomized controlled trial, theoretical advantages of dexmedetomidine showed no long-term outcome associations.
About two-thirds of patients were alive 2 months later.
